The USFDA conducted an inspection at the company's Baska facility from 8 September 2025 to 19 September 2025 and has ...

According to an exchange filing, the pharma major said the inspection took place between September 8 and September 19, 2025, ...

Mumbai: Sun Pharma has announced that the company has received Official Action Indicated (OAI) status from the U.S. Food and ...

Welcome to the Sun Pharma Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...

The dispute centres on Novo Nordisk's Indian patents for semaglutide, which it markets globally as Ozempic and Wegovy for ...

Get the latest Sun Pharma Advanced Research Company Ltd. share price today on NSE & BSE. Explore Sun Pharma Advanced Research Company Ltd. stock analysis, financial performance, market capitalization, ...

Sun Pharma informed the stock exchanges that the board of directors of its subsidiary Sun Pharma Laboratories approved the investment proposal of ₹3,000 crore to set up a greenfield formulations ...

Mumbai: Sun Pharma Laboratories Limited, a wholly owned subsidiary of Sun Pharma, is set to establish a Rs 3,000-crore ...

Sun Pharma Dividend 2025: Sun Pharma, the pharma company, is set to trade ex-date and record date on February 6, 2025. The state-run company announced a 1,050 per cent dividend payment on each stock ...

PRINCETON, N.J., Oct. 22, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma ...

The court, however, permitted Sun Pharma to manufacture and export semaglutide to non-patent countries, extending the same relief it granted Dr. Reddy’s Laboratories in a similar dispute earlier this ...